Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03195140 · ClinicalTrials.gov registry record · NA
Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial
A NA study of Diabetes Mellitus, Type 1, sponsored by Tandem Diabetes Care.
- Completed
- Registry status
- NA
- Development phase
- 103
- Enrollment target
- 4
- Study locations
NCT03195140 is a NA study of Diabetes Mellitus, Type 1 that has completed, run by Tandem Diabetes Care. The registered enrollment target is 103 participants, below the 1,265-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (92% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT03195140, a NA study of Diabetes Mellitus, Type 1, has completed, sponsored by Tandem Diabetes Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
- 4
- Study locations
Study Summary
A 6-week crossover study will compare PLGS to SAP outcomes in adults and youth \> 6 years old with type 1 diabetes (T1D).
Conditions Studied
Interventions
- DEVICE Predictive Low Glucose Suspend
Study Locations (4)
California
- Stanford University - Palo Alto
- William Sansum Diabetes Center - Santa Barbara
Colorado
- Barbara Davis Center - Aurora
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2017-08-11 |
| Est. Completion | 2018-02-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03195140
The ClinicalTrials.gov registry entry for NCT03195140 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,265-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (92% lower). The listed sponsor is Tandem Diabetes Care, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus, Type 1 appearing as the primary indexed condition, and to 1 intervention - of which Predictive Low Glucose Suspend is the first listed.
NCT03195140 reports 4 study locations spanning 3 distinct geographic areas - top geographies include California, Colorado, Connecticut.
Frequently Asked Questions
What is clinical trial NCT03195140 about?
NCT03195140 is a clinical study titled "Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial". A 6-week crossover study will compare PLGS to SAP outcomes in adults and youth \> 6 years old with type 1 diabetes (T1D).
What is the current status of trial NCT03195140?
This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2017-08-11. Estimated completion is 2018-02-06.
What conditions does trial NCT03195140 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 1.
What interventions are being tested in trial NCT03195140?
The interventions under investigation include: Predictive Low Glucose Suspend (DEVICE).
Who is sponsoring clinical trial NCT03195140?
This trial is sponsored by Tandem Diabetes Care, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03195140 being conducted?
This trial has 4 study locations across California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 1
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
-
Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes
RECRUITING · NA
-
National Institute of Diabetes and Digestive Kidney Diseases* Share Plus: Continuous Glucose Monitoring with Data Sharing in Older Adults with Type 1 Diabetes* and Their Care Partners to Improve Time in Range and Reduce Diabetes Distress.
RECRUITING · NA
-
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.